The morbidity and clinical features of unilateral pulmonary edema in the intensive care unit: A retrospective study
10.3760/cma.j.issn.1671-0282.2022.08.006
- VernacularTitle:单侧肺水肿在重症医学科中的发病率和临床特征-回顾性研究
- Author:
Wei WANG
1
;
Baojun YU
;
Shengyuan SU
;
Yuehui ZHANG
;
Li WANG
;
Ruijun CHEN
;
Lijun WANG
Author Information
1. 深圳大学附属第二医院重症医学科,深圳 518101
- Keywords:
Unilateral pulmonary edema;
Intensive Care Unit;
Mitral regurgitation
- From:
Chinese Journal of Emergency Medicine
2022;31(8):1049-1055
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the morbidity, clinical features and mortality of unilateral pulmonary edema (PE) in the intensive care unit (ICU).Methods:Clinical data of PE patients in ICU between January 2018 and January 2021 were retrospectively collected. All patients were divided into the bilateral PE and unilateral PE groups according to imaging manifestations. Etilogy, clinical performance, cardiac ultrasound parameters, complications, treatment and prognosis were compared between the two groups. Binary logistic regression analysis was used to screen out the risk factors of death.Results:Of the 314 PE patients, 14 (4.5%) were unilateral PE patients , and 11 (78.5%) were right-sided unilateral PE. There were no differences in age, gender, heart rate, respiratory rate and left ventricular eject fraction between the unilateral and bilateral PE groups. Compared with the bilateral PE group, systolic and diastolic blood pressure were significantly lower in the unilateral PE group [128 (102.7-138) mmHg vs. 135 (116-166) mmHg, 72 (54-88.2) mmHg vs. 82 (69-97.7)mmHg, respectively]. The incidence of cardiac arrest and hospital mortality were higher in the unilateral PE group [28.6% vs. 8.0%, 42.9% vs. 10%, all P<0.05]. Binary logistic regression analysis showed that age, unilateral PE, and use of vasoactive agent were associated with poor prognosis. Odds ratio of unilateral PE and use of vasoactive agent were 17.78 and 11.67, respectively. Conclusions:Unilateral PE is not rare, which is an independent risk factors for mortality and should be promptly recognized to avoid delays in treatment.
